Skip to content

Opening book details…

About this Medicine article

B1-02: A Phase 1-2 study of the anti-sense oligonucleotide OGX-011 in combination with a platinum/gemcitabine regimen as first-line therapy for advanced non-small cell lung cancer by Laskin, Janessa; Hao, Desiree; Canil, Christina; Lee, Christopher; Melosky, B; Stephenson, Joe; Vincent, Mark; Gitlitz, Barbara; Cheng, Susanna; Murray, Nevin is a Medicine article available to read on EtoBox.

It is typically read by researchers, students, and practitioners in Medicine.

Author
Laskin, Janessa; Hao, Desiree; Canil, Christina; Lee, Christopher; Melosky, B; Stephenson, Joe; Vincent, Mark; Gitlitz, Barbara; Cheng, Susanna; Murray, Nevin
Publisher
Elsevier ; Elsevier Inc.; Elsevier BV (ISSN 1556-1380)
Published
2007
Field
Medicine (Health Sciences)

More by Laskin, Janessa; Hao, Desiree; Canil, Christina; Lee, Christopher; Melosky, B; Stephenson, Joe; Vincent, Mark; Gitlitz, Barbara; Cheng, Susanna; Murray, Nevin

Browse all works by Laskin, Janessa; Hao, Desiree; Canil, Christina; Lee, Christopher; Melosky, B; Stephenson, Joe; Vincent, Mark; Gitlitz, Barbara; Cheng, Susanna; Murray, Nevin